RCKT
Rocket Pharmaceuticals, Inc.Company with tickers: RCKT, RCKTW
CIK
1281895
CUSIP
77313F106
Shares Outstanding
109,193,549
13F Activity (30d)
164 filings
159 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $0 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $48,511,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $31,454,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-48,511,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-47,594,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-0.42 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-0.42 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |